RT @LisaForKansas: ⚠️Important reminder Neither ❌the original vax NOR ❌bivalent vax NOR ❌prior infection w/ BA.2, 4 or 5 Have any decent…
RT @LisaForKansas: ⚠️Important reminder Neither ❌the original vax NOR ❌bivalent vax NOR ❌prior infection w/ BA.2, 4 or 5 Have any decent…
RT @LisaForKansas: ⚠️Important reminder Neither ❌the original vax NOR ❌bivalent vax NOR ❌prior infection w/ BA.2, 4 or 5 Have any decent…
RT @LisaForKansas: ⚠️Important reminder Neither ❌the original vax NOR ❌bivalent vax NOR ❌prior infection w/ BA.2, 4 or 5 Have any decent…
⚠️Important reminder Neither ❌the original vax NOR ❌bivalent vax NOR ❌prior infection w/ BA.2, 4 or 5 Have any decent neutralizing power vs newest XBB variants⬇️ They will not prevent infection❗️ ✅N95 or better in shared air H/T @flowermusickids http
RT @flowermusickids: @Ingridebap @Annalisa840917 @POTUS @ChrisMurphyCT @CDCgov - ALL, as in every single one, news articles extolling the v…
@Ingridebap @Annalisa840917 @POTUS @ChrisMurphyCT @CDCgov - ALL, as in every single one, news articles extolling the virtues of “hybrid immunity” has been refuted not only by the robust amount of SARS-CoV-2 transmission, the sky high morbidity that it’s ca
RT @flowermusickids: @nohomelikeplace @KathySlage Be advised, the study findings in Lancet extolling the virtues of “hybrid immunity” have…
RT @AbraarKaran: "Together, our findings indicate that BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render…
@Debunk_the_Funk @SJayToday And, once again, the conclusions of those studying both the newer variants and the effects of the virus. Coming to similar conclusions. Quit living on past accolades and come into the present funk. https://t.co/RoVjRuiB8E https:
@JeromeAdamsMD BIVALENT BIG FAIL https://t.co/O0JRhEoNyi
RT @flowermusickids: @TheMcKenziest Lauren, you’re correct. “Hybrid immunity” isn’t to be relied upon—it’s a dry well. Unfortunately, SARS2…
RT @flowermusickids: @nohomelikeplace @KathySlage Be advised, the study findings in Lancet extolling the virtues of “hybrid immunity” have…
RT @flowermusickids: @nohomelikeplace @KathySlage Be advised, the study findings in Lancet extolling the virtues of “hybrid immunity” have…
RT @flowermusickids: @TheMcKenziest Lauren, you’re correct. “Hybrid immunity” isn’t to be relied upon—it’s a dry well. Unfortunately, SARS2…
RT @flowermusickids: @nohomelikeplace @KathySlage Be advised, the study findings in Lancet extolling the virtues of “hybrid immunity” have…
RT @flowermusickids: @PeteUK7 This Lancet study cited in this “news” article has since been refuted by this one: https://t.co/y4HceVEhyo T…
RT @flowermusickids: @TheMcKenziest Lauren, you’re correct. “Hybrid immunity” isn’t to be relied upon—it’s a dry well. Unfortunately, SARS2…
@TheMcKenziest Lauren, you’re correct. “Hybrid immunity” isn’t to be relied upon—it’s a dry well. Unfortunately, SARS2 is far too fast. I wrote a tweet with links to both the Lancet study this “hybrid immunity” article was based upon as well as a second st
RT @flowermusickids: @PeteUK7 This Lancet study cited in this “news” article has since been refuted by this one: https://t.co/y4HceVEhyo T…
@nohomelikeplace Have not read this, but relevant https://t.co/rmCRceCGIX
@dee_latta 1-19-2023 “Recent BQ/XBB subvariants of SARS-2 demonstrate dramatically increased ability to evade neutralizing antibodies,even those from people who received the bivalent mRNA booster or who are immunized and had previous breakthrough Omicron
@Debunk_the_Funk @IanCopeland5 Well, since I am here I will also add the remarks from the two studies, showing similar concerns from different angles. https://t.co/xts4Y514Cr https://t.co/RoVjRui3j6 https://t.co/dUDCtS0c6X
@nohomelikeplace @KathySlage Be advised, the study findings in Lancet extolling the virtues of “hybrid immunity” have been refuted by this study: https://t.co/jEnjqadKbP (The Lancet article never assessed neutralization of XBB variants against vaccinated
@TheMcKenziest @LauraMiers Yes, the Lancet article (which did not study XBB variants) is likely being cited in those “news” articles. Be advised, those findings have been upended by this paper: https://t.co/y4HceVEhyo
RT @flowermusickids: @PeteUK7 This Lancet study cited in this “news” article has since been refuted by this one: https://t.co/y4HceVEhyo T…
RT @flowermusickids: @PeteUK7 This Lancet study cited in this “news” article has since been refuted by this one: https://t.co/y4HceVEhyo T…
RT @flowermusickids: @PeteUK7 This Lancet study cited in this “news” article has since been refuted by this one: https://t.co/y4HceVEhyo T…
@PeteUK7 This Lancet study cited in this “news” article has since been refuted by this one: https://t.co/y4HceVEhyo The Lancet article (here: https://t.co/TtkEP5OOOT) doesn’t take into account “hybrid immunity” against XBB.X.X variants….ooops 👇No hybrid
@fitterhappierAJ Citation for screenshot here: https://t.co/y4HceVEhyo https://t.co/ALmfnwNTDX
RT @norionakatsuji: 新たに感染拡大している新型コロナウイルス変異株が、今使われているワクチンや中和抗体による抑制効果から免れるだろう、という心配な最新研究結果のCell誌論文はこれだな。 “Alarming antibody evasion properti…
Foremost may be their extreme antibody evasion properties, especially considering the extensive herd immunity built up in the population over the last three years from infections and vaccinations. https://t.co/HzoPsGqFi1
The combination of mAbs known as Evusheld that is authorized for the prevention of COVID-19 is also completely inactive against the new subvariants. This poses a serious problem for millions of immunocompromised individuals. https://t.co/HzoPsGqFi1
Therefore, it is alarming that these newly emerged subvariants could further compromise the efficacy of current COVID-19 vaccines and result in a surge of breakthrough infections as well as re-infections. https://t.co/HzoPsGqFi1
Our data demonstrate that these new subvariants were barely susceptible to neutralization by sera from vaccinated individuals with or without prior infection, including persons recently boosted with the new bivalent (WA1/BA.5). https://t.co/6KOVmWh6DE
Our data demonstrate that these new subvariants were barely susceptible to neutralization by sera from vaccinated individuals with or without prior infection, including persons recently boosted with the new bivalent (WA1/BA.5) https://t.co/HzoPsGqFi1
The BQ and XBB subvariants of SARS-CoV-2 Omicron are now rapidly expanding, possibly due to altered antibody evasion properties deriving from their additional spike mutations. https://t.co/HzoPsGqFi1
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. https://t.co/HzoPsGqFi1
@DrHirschfield @JeromeAdamsMD The BIVALENT performance is dismal https://t.co/O0JRhEoNyi
RT @AbraarKaran: "Together, our findings indicate that BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render…
RT @Lucky17171717: @wxyzdetroit 1-19-2023 “Recent BQ-XBB subvariants of SARS-2 demonstrate dramatically increased ability to evade neutrali…
@wxyzdetroit 1-19-2023 “Recent BQ-XBB subvariants of SARS-2 demonstrate dramatically increased ability to evade neutralizing antibodies, even those from people who received the bivalent mRNA booster or who are immunized and had previous breakthrough Omicro
@LorentzuvFaktor @AlterovoEgo Jj, díky. O tomto článku vím 👇 Podezření, ze s BQ.1.* a XBB.1.* bude problém, tušíme tak od října, ale dosud se to u nas v datech nějak neukázalo. Počítám, že za dva měsíce uslyšíme z ČT něco jako "nikdo to nemohl čekat".🤷♂️
@AlterovoEgo @KarabaAdam 👇 Subvarianty se "naučily" obcházet imunitu. https://t.co/DmhGiz3sSO
@IanCopeland5 The BIVALENT IS USELESS https://t.co/O0JRhEoNyi
@AlBowers1 @IanCopeland5 @FreedomKiwi The BIVALENT is useless https://t.co/O0JRhEoNyi
@maggiemae362 @alexmeshkin Yes. And this one. https://t.co/dVQ4IoxlfJ
@FatherJenkinsND @NotreDame @ndwbb @NDWomensTennis @NDXCTF @NDSoccer @FightingIrish DROP THE MANDATES NOW🛑 1-19-2023 “BQ-XBB SARS2 demonstrate dramatically increased ability to evade neutralizing antibodies, even those from people who received the bivalent
@redwondereroft1 @IanCopeland5 Blocked. For anyone not trying to be argumentative. This is what they say at the end of the discussion. https://t.co/xts4Y51CrZ https://t.co/RFi3s8E5V6
@redwondereroft1 @IanCopeland5 No. You are ignoring what I just said and the evidence from newer studies with current sub variants. Like the Cleveland Clinic study and others that look at Ab levels. Like this one. That ended with this: https://t.co/xts4Y51
@redwondereroft1 @IanCopeland5 Sorry, a different part of the thread. And yes. I have read what I link. https://t.co/8EVXioxaDP
@IanCopeland5 Or this study about immune evasion by the more recent subvariants, with these comments. /2 https://t.co/xts4Y51CrZ https://t.co/JSxwyDRuZS
@PolAdIntel14 @IanCopeland5 1-19-2023 “Recent BQ XBB subvariants of SARS--2 demonstrate dramatically increased ability to evade neutralizing antibodies,even those from people who received the bivalent mRNA booster or who are immunized and had previous brea
RT @xjR1BqbrppuegLj: @kutsunasatoshi XBBは💉中和抗体が既にほぼ誘導されないとわかっているので、💉以外の事をまず提案すべきかと思うのですが如何でしょうか? https://t.co/It6ogx8Xjs 記事内で「中和抗体の上昇が見られた」…
@ScottTheRockS @PierreJoliat @KhNyMd @realstewpeters There are several studies concerned about the evolution immune evasion of newer subvariants. Evolution that may actually be accelerated or driven by the vaccines. /2 https://t.co/xts4Y51CrZ https://t.co/
RT @Lucky17171717: @YaleSPH @meganranney 1-19-2023 “Recent BQ and XBB subvariants of SARS-CoV-2 demonstrate dramatically increased ability…
RT @Lucky17171717: @YaleSPH @meganranney 1-19-2023 “Recent BQ and XBB subvariants of SARS-CoV-2 demonstrate dramatically increased ability…
@YaleSPH @meganranney 1-19-2023 “Recent BQ and XBB subvariants of SARS-CoV-2 demonstrate dramatically increased ability to evade neutralizing antibodies, even those from people who received the bivalent mRNA booster..💡 https://t.co/QzW9WLH0Jw https://t.co/
@DrEricDing Hello Dr. Feigl-Ding. I have some concerns about the Dr. Schinazi quote being used in this article. They are very likely misrepresenting his position. To my knowledge, Dr. Schinazi is being quoted out of context. Please consider revising that p
RT @manuelmuro5: Menos mal que la respuesta celular es la más potente y duradera. Muestran que la neutralización de BQ.1, BQ.1.1, XBB y XBB…
RT @manuelmuro5: Menos mal que la respuesta celular es la más potente y duradera. Muestran que la neutralización de BQ.1, BQ.1.1, XBB y XBB…
RT @manuelmuro5: Menos mal que la respuesta celular es la más potente y duradera. Muestran que la neutralización de BQ.1, BQ.1.1, XBB y XBB…
@cbotnyse @Freeyourmindkid Who “we” got lucky? Those who died with/because of? Those who continue suffering the effects months/years later? Those immunocompromised trapped in a no where to go landscape? And who said the variants were mild? Shameful is @m
RT @manuelmuro5: Menos mal que la respuesta celular es la más potente y duradera. Muestran que la neutralización de BQ.1, BQ.1.1, XBB y XBB…
Menos mal que la respuesta celular es la más potente y duradera. Muestran que la neutralización de BQ.1, BQ.1.1, XBB y XBB.1 por sueros de vacunados e infectados fue afectada, incluidos reforzados con vacuna de ARNm bivalente WA1/BA.5 https://t.co/8s0ar1c
@abcnews The more jabs you get, the more likely you are to get infected: https://t.co/0Sm3pmYDDk Current vaccines have driven antigenic drift to the point of being useless. BQ & XBB have escaped. https://t.co/Fm8GzlGYJM Were policy makers warned of a
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants - Cell https://t.co/1elcSiT5QX Volume 186, Issue 2, 19 January 2023, Pages 279-286.e8 https://t.co/5LGL64fiMY
@DannySports86 @pamelaad116 @DrEricDing flu is a respiratory virus. Vaccines were created for wild type. Bivalents addressed Omicron variants B4/5. Now, 50% of sequenced cases are XBB.1.5. -vaccines do not stop transmission -no therapeutics work for new v
RT @RealCheckMarker: #Incurable In case anyone was unaware the XBB and BQ variants changed the effectiveness of bivalent vaccines: "Alarmi…
L'étude démontrant l'inefficacité d' Evusheld pour la Covid vient d'être prise en compte par le Ministère qui ne conseille plus ce produit La même étude démontre la totale inefficacité des vaccins Covid sur les variants actuels @FrcsBraun : faut tout lire!
Bien en retard sur Les Patriotes, mais ça y'est un DGS urgent ne recommande plus l'usage de l'EVUSHELD en traitement de la Covid Si ils nous écoutaient ... que d'économies pour les finances de la République https://t.co/q3NZAAJdl9
@ARSCORSE1 Amis Corses Vous voulez des réponses ... alors lisez https://t.co/rr78TesAaE
#Incurable In case anyone was unaware the XBB and BQ variants changed the effectiveness of bivalent vaccines: "Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants" https://t.co/bBmQoNQ3b8 https://t.co/TG2RAaWPHt
@CDCgov Wake UP JANUARY 2023 “meaning there are now no clinically authorized therapeutic antibodies effective against these circulating variants” https://t.co/QzW9WLH0Jw https://t.co/9WeT2i40RJ
@JeromeAdamsMD Jan-2023 “Recent BQ +XBB subvariants of SARS-2 demonstrate dramatically increased ability to evade neutralizing antibodies, even those from people who received the bivalent mRNA booster or who are immunized and had previous breakthrough Omic
@str8shooter123 @LeeCraddock12 Tbh it’s all failed (except natural immunity)… non neutralizing selective pressure places selective pressure on viruses 🦠 VIROLOGY 101 https://t.co/QzW9WLH0Jw https://t.co/b7EPYJIeYD
@JeromeAdamsMD January 2023 Cell “meaning there are now no clinically authorized therapeutic antibodies effective against these circulating variants” Over 89% of the circulating VOC (variant of concern) is XBB 1.5 BQ.1.1 & BQ.1 BIVALENT was created fo
@P_McCulloughMD January 2023 Cell “meaning there are now no clinically authorized therapeutic antibodies effective against these circulating variants” Over 89% of the circulating VOC (variant of concern) is XBB 1.5 BQ.1.1 & BQ.1 BIVALENT/B4-5<3% h
@JeromeAdamsMD @Mikeska January 2023 Cell “meaning there are now no clinically authorized therapeutic antibodies effective against these circulating variants” Over 89% of the circulating VOC (variant of concern) is XBB 1.5 BQ.1.1 & BQ.1 BIVALENT was c
@Debunk_the_Funk @LacBougie @DohoGg @DrSyedHaider Just to make this complete, the warnings from papers I have asked you to *debunk* if you can. Is @InWuchang right? Can you say nothing negative about the current vaccines? https://t.co/RoVjRuiB8E https://t
RT @tak53381102: オミクロン用二価ワクチンを接種した人やBA.5に感染した人の血清抗体は新規変異株に対して中和活性を持つかどうか(Cell. 2022 Dec 14). 既報同様、二価ワクチン接種後も、BA.5感染しても、抗体はXBBを中和しない。できるだけ日本…
@DrFranckClarot Efficacité nulle ou quasi nulle … https://t.co/a8pF3SaOg5
RT @AbraarKaran: "Together, our findings indicate that BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render…
But do they go far enough. Are we acknowledging the warnings being posed by those who are looking at the new variants? https://t.co/RoVjRuiB8E https://t.co/xts4Y51CrZ https://t.co/11tQiDNg9d
@healthbyjames self-fulfilling #predestination
RT @LautesS: Neueste Daten Belegen eindeutig: mRNA Impfung ist gegen neuesten Corona Varianten WIRKINGSLOS! Meine Patienten bekommen eine…